Hyperfine receives Nasdaq deficiency notice for bid price below $1.00

Hyperfine, Inc.

Closing bid price of HYPR common stock below $1.00 for 30 consecutive business days.
180-day compliance period to regain bid price requirement, ending November 25, 2024.
If not cured, Company may seek transfer to Nasdaq Capital Market for an additional 180 days.
No immediate impact on listing or trading of Common Stock under symbol 'HYPR'.
Company evaluating options to regain compliance; delisting risk if unable to cure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.